Effects of respiratory motion on passively scattered proton therapy versus intensity modulated photon therapy for stage III lung cancer

Are proton plans more sensitive to breathing motion?

Jason Matney, Peter C. Park, Jaques Bluett, Yi Pei Chen, Wei Liu, Laurence E. Court, Zhongxing Liao, Heng Li, Radhe Mohan

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose To quantify and compare the effects of respiratory motion on paired passively scattered proton therapy (PSPT) and intensity modulated photon therapy (IMRT) plans; and to establish the relationship between the magnitude of tumor motion and the respiratory-induced dose difference for both modalities. Methods and Materials In a randomized clinical trial comparing PSPT and IMRT, radiation therapy plans have been designed according to common planning protocols. Four-dimensional (4D) dose was computed for PSPT and IMRT plans for a patient cohort with respiratory motion ranging from 3 to 17 mm. Image registration and dose accumulation were performed using grayscale-based deformable image registration algorithms. The dose-volume histogram (DVH) differences (4D-3D [3D = 3-dimensional]) were compared for PSPT and IMRT. Changes in 4D-3D dose were correlated to the magnitude of tumor respiratory motion. Results The average 4D-3D dose to 95% of the internal target volume was close to zero, with 19 of 20 patients within 1% of prescribed dose for both modalities. The mean 4D-3D between the 2 modalities was not statistically significant (P<.05) for all dose-volume histogram indices (mean ± SD) except the lung V5 (PSPT: +1.1% ± 0.9%; IMRT: +0.4% ± 1.2%) and maximum cord dose (PSPT: +1.5 ± 2.9 Gy; IMRT: 0.0 ± 0.2 Gy). Changes in 4D-3D dose were correlated to tumor motion for only 2 indices: dose to 95% planning target volume, and heterogeneity index. Conclusions With our current margin formalisms, target coverage was maintained in the presence of respiratory motion up to 17 mm for both PSPT and IMRT. Only 2 of 11 4D-3D indices (lung V5 and spinal cord maximum) were statistically distinguishable between PSPT and IMRT, contrary to the notion that proton therapy will be more susceptible to respiratory motion. Because of the lack of strong correlations with 4D-3D dose differences in PSPT and IMRT, the extent of tumor motion was not an adequate predictor of potential dosimetric error caused by breathing motion.

Original languageEnglish (US)
Pages (from-to)576-582
Number of pages7
JournalInternational Journal of Radiation Oncology Biology Physics
Volume87
Issue number3
DOIs
StatePublished - Nov 1 2013
Externally publishedYes

Fingerprint

Proton Therapy
breathing
Photons
lungs
Protons
therapy
Lung Neoplasms
Respiration
cancer
dosage
protons
photons
Therapeutics
tumors
Neoplasms
histograms
planning
Lung
spinal cord
Spinal Cord

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation
  • Cancer Research

Cite this

Effects of respiratory motion on passively scattered proton therapy versus intensity modulated photon therapy for stage III lung cancer : Are proton plans more sensitive to breathing motion? / Matney, Jason; Park, Peter C.; Bluett, Jaques; Chen, Yi Pei; Liu, Wei; Court, Laurence E.; Liao, Zhongxing; Li, Heng; Mohan, Radhe.

In: International Journal of Radiation Oncology Biology Physics, Vol. 87, No. 3, 01.11.2013, p. 576-582.

Research output: Contribution to journalArticle

Matney, Jason ; Park, Peter C. ; Bluett, Jaques ; Chen, Yi Pei ; Liu, Wei ; Court, Laurence E. ; Liao, Zhongxing ; Li, Heng ; Mohan, Radhe. / Effects of respiratory motion on passively scattered proton therapy versus intensity modulated photon therapy for stage III lung cancer : Are proton plans more sensitive to breathing motion?. In: International Journal of Radiation Oncology Biology Physics. 2013 ; Vol. 87, No. 3. pp. 576-582.
@article{9f553a12bc814637b48d576f036d47f3,
title = "Effects of respiratory motion on passively scattered proton therapy versus intensity modulated photon therapy for stage III lung cancer: Are proton plans more sensitive to breathing motion?",
abstract = "Purpose To quantify and compare the effects of respiratory motion on paired passively scattered proton therapy (PSPT) and intensity modulated photon therapy (IMRT) plans; and to establish the relationship between the magnitude of tumor motion and the respiratory-induced dose difference for both modalities. Methods and Materials In a randomized clinical trial comparing PSPT and IMRT, radiation therapy plans have been designed according to common planning protocols. Four-dimensional (4D) dose was computed for PSPT and IMRT plans for a patient cohort with respiratory motion ranging from 3 to 17 mm. Image registration and dose accumulation were performed using grayscale-based deformable image registration algorithms. The dose-volume histogram (DVH) differences (4D-3D [3D = 3-dimensional]) were compared for PSPT and IMRT. Changes in 4D-3D dose were correlated to the magnitude of tumor respiratory motion. Results The average 4D-3D dose to 95{\%} of the internal target volume was close to zero, with 19 of 20 patients within 1{\%} of prescribed dose for both modalities. The mean 4D-3D between the 2 modalities was not statistically significant (P<.05) for all dose-volume histogram indices (mean ± SD) except the lung V5 (PSPT: +1.1{\%} ± 0.9{\%}; IMRT: +0.4{\%} ± 1.2{\%}) and maximum cord dose (PSPT: +1.5 ± 2.9 Gy; IMRT: 0.0 ± 0.2 Gy). Changes in 4D-3D dose were correlated to tumor motion for only 2 indices: dose to 95{\%} planning target volume, and heterogeneity index. Conclusions With our current margin formalisms, target coverage was maintained in the presence of respiratory motion up to 17 mm for both PSPT and IMRT. Only 2 of 11 4D-3D indices (lung V5 and spinal cord maximum) were statistically distinguishable between PSPT and IMRT, contrary to the notion that proton therapy will be more susceptible to respiratory motion. Because of the lack of strong correlations with 4D-3D dose differences in PSPT and IMRT, the extent of tumor motion was not an adequate predictor of potential dosimetric error caused by breathing motion.",
author = "Jason Matney and Park, {Peter C.} and Jaques Bluett and Chen, {Yi Pei} and Wei Liu and Court, {Laurence E.} and Zhongxing Liao and Heng Li and Radhe Mohan",
year = "2013",
month = "11",
day = "1",
doi = "10.1016/j.ijrobp.2013.07.007",
language = "English (US)",
volume = "87",
pages = "576--582",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Effects of respiratory motion on passively scattered proton therapy versus intensity modulated photon therapy for stage III lung cancer

T2 - Are proton plans more sensitive to breathing motion?

AU - Matney, Jason

AU - Park, Peter C.

AU - Bluett, Jaques

AU - Chen, Yi Pei

AU - Liu, Wei

AU - Court, Laurence E.

AU - Liao, Zhongxing

AU - Li, Heng

AU - Mohan, Radhe

PY - 2013/11/1

Y1 - 2013/11/1

N2 - Purpose To quantify and compare the effects of respiratory motion on paired passively scattered proton therapy (PSPT) and intensity modulated photon therapy (IMRT) plans; and to establish the relationship between the magnitude of tumor motion and the respiratory-induced dose difference for both modalities. Methods and Materials In a randomized clinical trial comparing PSPT and IMRT, radiation therapy plans have been designed according to common planning protocols. Four-dimensional (4D) dose was computed for PSPT and IMRT plans for a patient cohort with respiratory motion ranging from 3 to 17 mm. Image registration and dose accumulation were performed using grayscale-based deformable image registration algorithms. The dose-volume histogram (DVH) differences (4D-3D [3D = 3-dimensional]) were compared for PSPT and IMRT. Changes in 4D-3D dose were correlated to the magnitude of tumor respiratory motion. Results The average 4D-3D dose to 95% of the internal target volume was close to zero, with 19 of 20 patients within 1% of prescribed dose for both modalities. The mean 4D-3D between the 2 modalities was not statistically significant (P<.05) for all dose-volume histogram indices (mean ± SD) except the lung V5 (PSPT: +1.1% ± 0.9%; IMRT: +0.4% ± 1.2%) and maximum cord dose (PSPT: +1.5 ± 2.9 Gy; IMRT: 0.0 ± 0.2 Gy). Changes in 4D-3D dose were correlated to tumor motion for only 2 indices: dose to 95% planning target volume, and heterogeneity index. Conclusions With our current margin formalisms, target coverage was maintained in the presence of respiratory motion up to 17 mm for both PSPT and IMRT. Only 2 of 11 4D-3D indices (lung V5 and spinal cord maximum) were statistically distinguishable between PSPT and IMRT, contrary to the notion that proton therapy will be more susceptible to respiratory motion. Because of the lack of strong correlations with 4D-3D dose differences in PSPT and IMRT, the extent of tumor motion was not an adequate predictor of potential dosimetric error caused by breathing motion.

AB - Purpose To quantify and compare the effects of respiratory motion on paired passively scattered proton therapy (PSPT) and intensity modulated photon therapy (IMRT) plans; and to establish the relationship between the magnitude of tumor motion and the respiratory-induced dose difference for both modalities. Methods and Materials In a randomized clinical trial comparing PSPT and IMRT, radiation therapy plans have been designed according to common planning protocols. Four-dimensional (4D) dose was computed for PSPT and IMRT plans for a patient cohort with respiratory motion ranging from 3 to 17 mm. Image registration and dose accumulation were performed using grayscale-based deformable image registration algorithms. The dose-volume histogram (DVH) differences (4D-3D [3D = 3-dimensional]) were compared for PSPT and IMRT. Changes in 4D-3D dose were correlated to the magnitude of tumor respiratory motion. Results The average 4D-3D dose to 95% of the internal target volume was close to zero, with 19 of 20 patients within 1% of prescribed dose for both modalities. The mean 4D-3D between the 2 modalities was not statistically significant (P<.05) for all dose-volume histogram indices (mean ± SD) except the lung V5 (PSPT: +1.1% ± 0.9%; IMRT: +0.4% ± 1.2%) and maximum cord dose (PSPT: +1.5 ± 2.9 Gy; IMRT: 0.0 ± 0.2 Gy). Changes in 4D-3D dose were correlated to tumor motion for only 2 indices: dose to 95% planning target volume, and heterogeneity index. Conclusions With our current margin formalisms, target coverage was maintained in the presence of respiratory motion up to 17 mm for both PSPT and IMRT. Only 2 of 11 4D-3D indices (lung V5 and spinal cord maximum) were statistically distinguishable between PSPT and IMRT, contrary to the notion that proton therapy will be more susceptible to respiratory motion. Because of the lack of strong correlations with 4D-3D dose differences in PSPT and IMRT, the extent of tumor motion was not an adequate predictor of potential dosimetric error caused by breathing motion.

UR - http://www.scopus.com/inward/record.url?scp=84884834472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884834472&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2013.07.007

DO - 10.1016/j.ijrobp.2013.07.007

M3 - Article

VL - 87

SP - 576

EP - 582

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 3

ER -